ScienceDex / Researcher record
Matthew M. Gubin
- UT MD Anderson Cancer Center · Microbiology & Immunology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $606,635 | 1 | #26,197 |
| 2025 | $606,635 | 1 | #27,448 |
| 2026 | $1,819,905 | 1 | #11,480 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected1 record
- FY20251 record
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11439041Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-7443-2752Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Microbiology & Immunology
FY2024 award records by amount
NIH award records listing Matthew M. Gubin as a PI. Multi-PI records show the full award amount for context.
- 1R01CA282027-01A1R01Contact PIBhlhe40 Regulation of T Cell Function During Cancer ImmunotherapyUT MD Anderson Cancer Center · Microbiology & Immunology (NIH department code)$606.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing Matthew M. Gubin as a PI.
FY2024 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT MD Anderson Cancer Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding